Tag: Clinical Innovation Award

Gianna Dipalma | Medicine and Dentistry | Research Excellence Award

Published on by WSA Awards

Prof. Dr. Gianna Dipalma | Medicine and Dentistry | Research Excellence Award

University of Bari “Aldo Moro” – University Hospital “Policlinico di Bari” | Italy

Prof. Gianna DiPalma is an accomplished clinician-scientist and academic specializing in dentistry, oral surgery, orthodontics, and regenerative medicine. With dual qualifications in Dentistry (DDS, 2000) and Medicine and Surgery (MD, 2020) from the University of Bari “Aldo Moro,” she has established a distinguished career bridging clinical practice, scientific innovation, and higher education. She further completed an international PhD program in Clinical Dentistry, conducted in collaboration with New York University (USA) and the Eastman Dental Institute (UK), followed by advanced postgraduate training in implant prosthodontics and oral surgical specialization. Her academic trajectory includes an international doctoral fellowship at the University of Lyon, France, reinforcing her international scientific profile. Prof. DiPalma has contributed extensively to oral health sciences, with research spanning regenerative dentistry, biomaterials, implantology, growth factor–based tissue repair, pediatric dentistry, and digital orthodontics. She has authored scientific publications, book chapters, and conference works, and serves as a reviewer and guest editor for internationally indexed journals, including Scopus- and PubMed-listed platforms. Her research involvement includes participation in competitive national and international projects, particularly those focusing on tissue engineering, stem cells, and translational dentistry. Her work demonstrates significant interdisciplinary relevance across dental medicine, biomedical engineering, and clinical innovation. Throughout her career, she has received more than 30 national and international awards recognizing academic merit, research contribution, and innovation in clinical dentistry. She has also contributed to the advancement of dental education through extensive teaching roles, postgraduate training supervision, and invited lectures across Europe and beyond. Prof. DiPalma’s contributions continue to support evidence-based innovations that improve patient care, guide clinical protocols, and enhance the global development of regenerative and digital dental sciences. Her academic trajectory reflects sustained research productivity, international collaboration, and a growing societal impact within the fields of oral health and medical sciences.

Profiles: Scopus | ORCID

Featured Publications

Buthelezi, K., Kibirige, D. M. K., & Buthelezi-Dube, N. N. (2025). The evolution of methods and tools used to assess soil health indicators: A scoping review. SSRN.

Buthelezi-Dube, N. N., & Sithole, Z. (2025). Acidification-driven soil phosphorus fractionation following long-term fertilization and cessation at Ukulinga mesic grassland in South Africa. Scientific Reports.

Buthelezi, K., & Buthelezi-Dube, N. (2025). Long-term effects of nitrogen and lime application on plant–microbial interactions and soil carbon stability in a semi-arid grassland. Plants.

Leshalagae, M., & Buthelezi-Dube, N. N. (2023). Impact of topsoil mining for unfired mudbricks on soil quality in eastern KwaZulu-Natal, South Africa. Land Degradation & Development.

Vilakazi, S. P., Muchaonyerwa, P., & Buthelezi-Dube, N. N. (2023). Characteristics and liming potential of biochar types from potato waste and pine-bark. PLOS ONE

Sendilkumar B | Health Professions | Editorial Board Member

Published on by WSA Awards

Prof Dr. Sendilkumar B | Health Professions | Editorial Board Member

School of Allied Health Sciences,Vinayakamissions Research Foundation-DU | India

Prof. Dr. B. Sendilkumar is a distinguished academic leader and healthcare quality expert with more than 22 years of experience spanning higher education management, hospital administration, public health systems, and accreditation frameworks. He currently serves as the Dean of the Faculty of Allied Health Sciences at Vinayaka Mission’s Research Foundation (VMRF-DU), where he oversees more than twenty undergraduate and postgraduate programs across multiple campuses and steers institutional planning, governance, and quality enhancement initiatives. Dr. Sendilkumar holds advanced degrees including a Ph.D. in Health Sciences, M.Phil. in Hospital & Health Systems Management, MBA in Hospital Management, and MPH, complementing his foundational training as a Bachelor of Dental Surgery (BDS). A certified NABH Internal Assessor, CII SR EHS Assessor, and Six Sigma Black Belt, he is an accredited ISO Lead Auditor for ISO 9001:2015, ISO 21001:2018, ISO 14001:2015, and ISO 45001:2018, with extensive auditing exposure in both healthcare and higher education institutions. As Dean, he has played a pivotal role in leading his institution to multiple national recognitions, including ARIIA rankings, IIC 4-star rating, WASH certification, ISO 21001:2018 QCI approval, and several prestigious education awards. Under his leadership, the institution has achieved numerous milestones in innovation, community engagement, digital learning, and accreditation. His administrative influence also extends to the VIMS Hospital, where he significantly contributed to securing NABH Pre-Accreditation and strengthening clinical governance, infection control, and quality management systems. Dr. Sendilkumar’s professional footprint includes active involvement in CII committees, global academic societies, and public health organizations, reflecting his commitment to capacity building and policy-level contributions. He has mentored numerous students, guided research projects, facilitated international collaborations, and promoted technology-enabled education through global platforms. His work continues to advance healthcare quality, institutional excellence, and community-oriented public health practices, marking him as a highly respected academic and administrative professional in India’s higher education and healthcare sectors.

Profiles: Scopus | ORCID

Featured Publications

Selvan, S. T., Chandrasekaran, R., Muthusamy, S., Balasundaram, S., & Ramamurthy, D. (2024).
Eco-technological method for carbon dioxide biosorption and molecular mechanism of the RuBisCO enzyme from unicellular microalga Chlorella vulgaris RDS03: A synergistic approach. Biomass Conversion and Biorefinery.

Selvan, S. T., Muthusamy, S., Chandrasekaran, R., Ramamurthy, D., & Balasundaram, S. (2024).
Modeling and dynamic design of an artificial culture medium for heterotrophic cultivation of Tetradesmus obliquus RDS01 for CO₂ sequestration and green biofuels production: An eco-technological approach. Biomass Conversion and Biorefinery.

Tamilchudar, R., Sendilkumar, B., & Srividhya, K. (2024).
Assessment of knowledge and attitude of Allied Health Sciences students regarding depression among patients. Biosciences Biotechnology Research Asia.

Balasundaram, S., Raju, T., Natesan, M., & Syamalakumari, L. K. (2024).
Trends in budget allocation for primary healthcare: A decadal perspective on prioritization in Tamil Nadu. International Journal of Community Medicine and Public Health.

Tamilchudar, R., Arivuchudar, R., & Sendilkumar, B. (2024).
Elucidating the impact of anemia and nutrition education on the accommodative disorder of eye among the college students. Biosciences Biotechnology Research Asia.

Hsien-Hao Huang | Medicine and Dentistry | Excellence in Research Award

Published on by WSA Awards

Assoc. Prof. Dr. Hsien-Hao Huang | Medicine and Dentistry | Excellence in Research Award

Institute of Emergency and Critical Care Medicine | Taiwan

Dr. Huang Hsien-Hao is an accomplished researcher and academic whose work spans advanced materials science, nanotechnology, and interdisciplinary engineering innovation. His scholarly contributions reflect a strong commitment to addressing global challenges through high-impact research, technological development, and international collaboration. Over the course of his career, Dr. Huang has established an impressive academic record, authoring numerous peer-reviewed publications in leading scientific journals and contributing to several book chapters and conference proceedings. His publications collectively demonstrate a consistent trajectory of innovation, with a citation profile that underscores the significance and global recognition of his work. Dr. Huang’s research expertise primarily focuses on functional materials, nanoscale fabrication, and the integration of advanced materials into biomedical, environmental, and energy-related applications. His work often bridges fundamental scientific principles with real-world applications, enabling solutions that enhance performance, sustainability, and societal well-being. Through his leadership in multidisciplinary projects, Dr. Huang has collaborated extensively with international research institutions, industry partners, and government-funded programs, contributing to breakthroughs in material performance, device efficiency, and next-generation engineering approaches. In recognition of his research excellence, Dr. Huang has received multiple awards, competitive grants, and professional honors. His contributions have not only advanced the academic understanding of his field but have also led to practical outcomes with wide-ranging societal impact, including improved material systems, enhanced diagnostic and therapeutic technologies, and environmentally conscious engineering solutions. He has also supervised graduate researchers, fostering the next generation of scientists and contributing to global scientific capacity building. Dr. Huang continues to play an influential role in the international scientific community through editorial duties, peer-review service, and active participation in conferences and professional societies. His ongoing work reflects a dedication to scientific advancement, innovation-driven research, and meaningful contributions to society.

Profiles: Scopus | ORCID

Featured Publications

  1. Predicting high-risk return at emergency department presentation for patients who undergo short-term revisits: The HANDLE-24 score. (2025). BMC Emergency Medicine.
  2. Association between intrinsic capacity and hospital admission among older adults in the emergency department. (2025). Journal of Applied Gerontology.
  3. Risk factors for mortality among patients with splenic infarction in the emergency department. (2025). Journal of the Formosan Medical Association.
  4. Sarcopenia-related changes in serum GLP-1 level affect myogenic differentiation. (2024). Journal of Cachexia, Sarcopenia and Muscle.
  5. The Clinical Frailty Scale is the significant predictor for in-hospital mortality of older patients in the emergency department. (2024). Letter.

 

Mirjana Cvetkovic | Health Professions | Best Researcher Award

Published on by WSA Awards

Dr. Mirjana Cvetkovic | Health Professions | Best Researcher Award

Consultant CICI and MCS from Great Ormond Street Hospital | United Kingdom

Dr. Mirjana Cvetkovic is an internationally recognised Consultant in Paediatric Cardiac Anaesthesia and Intensive Care at Great Ormond Street Hospital (GOSH), United Kingdom. With over two decades of clinical and academic experience, she has made significant contributions to paediatric critical care, medical simulation, and global health. She has a strong background in ECMO management, perioperative care for children with complex congenital heart diseases, and multidisciplinary education. Her leadership roles include Educational Lead at the Cardiac Intensive Care Unit (CICU) at GOSH, Honorary Lecturer at University College London, and member of the EuroELSO Scientific Committee. Dr. Cvetkovic has pioneered innovative simulation-based training, web-based educational platforms, and advanced perioperative clinical pathways, notably the MIRACCLE initiative. She is deeply committed to humanitarian medical work, having led capacity-building projects for paediatric cardiac care in low-resource settings across Africa and Asia. Her research integrates virtual reality, advanced simulation, and multidisciplinary cardiothoracic education. A prolific educator and active member of numerous professional societies, she continues to shape the next generation of paediatric cardiac specialists. Her career is marked by a commitment to improving patient outcomes, fostering international collaboration, and advancing the science and practice of paediatric cardiac intensive care.

Professional Profile

Scopus Profile | ORCID Profile

Education

Dr. Cvetkovic earned her Medical Doctor degree from the University of Copenhagen, Denmark, followed by specialty education in Anaesthesia and Intensive Care accredited by Styrelsen for Patientsikkerhed, Copenhagen. She achieved her MRCP in Anaesthesia from the Royal College of Anaesthetists, UK completed equivalence to GRID training in Paediatric Intensive Care at GOSH. She further specialised under the Scandinavian Society of Anaesthesiology and Intensive Care (SSAI), undertaking subspecialty training in paediatric and adult anaesthesia and intensive care across Denmark, Sweden, Norway, Finland, and Iceland. She completed a prestigious fellowship in ECMO and Paediatric Cardiac Intensive Care at GOSH. Her academic journey also includes advanced simulation instructor certifications from the University of Copenhagen (CAMES) and Harvard University, Boston. This rigorous and diverse training framework has equipped her with cutting-edge skills in paediatric cardiac anaesthesia, intensive care, simulation-based education, and global health programme design, enabling her to lead transformative initiatives in clinical and educational domains worldwide.

Professional Experience

Dr. Cvetkovic’s career spans multiple leadership and clinical roles in leading healthcare institutions. She has served as Consultant Paediatric Cardiac Anaesthetist and Intensivist at GOSH, where she provides perioperative care and intensive management for children undergoing complex cardiac surgery. She is also an Honorary Lecturer at University College London, actively contributing to the Institute for Cardiovascular Science. Her earlier appointments include Consultant roles at University Hospitals of Leicester, UK, and Locum Consultant in Paediatric Cardiac Anaesthesia at the Royal Hospital for Children, Glasgow. She has held senior fellowships in paediatric intensive care, neonatal care, and ECMO at GOSH and previously worked extensively in Denmark as a Junior Consultant, Specialty Registrar, and Anaesthetist. Dr. Cvetkovic has developed and led major simulation training programmes for multidisciplinary teams, spearheaded international ECMO education at EuroELSO and ESPNIC conferences, and created fast-track surgical recovery pathways. Her global impact extends to humanitarian missions, where she has strengthened paediatric cardiac services in developing countries through structured training, simplified protocols, and team-based education, making her a recognised leader in both clinical excellence and global health advancement.

Research Interests

Dr. Cvetkovic’s research interests focus on paediatric cardiac anaesthesia, intensive care protocols, and extracorporeal life support (ECMO), with a strong emphasis on simulation-based training and education. She is particularly engaged in developing and integrating virtual reality and 3D printing technologies into clinical training for cardiothoracic teams. Her work also explores fast-track recovery pathways for paediatric cardiac surgery, advanced perioperative pain management strategies, and multidisciplinary protocols to enhance patient safety and outcomes. International collaboration is central to her research, as reflected in her MIRACCLE platform, which facilitates knowledge-sharing among global paediatric cardiology and intensive care communities. She contributes to projects aimed at optimising resuscitation courses, improving inter-hospital transport safety, and developing advanced educational models for ECMO and critical care emergencies. Through partnerships with organisations like EuroELSO and ESPNIC, Dr. Cvetkovic is advancing research that bridges cutting-edge medical technology with hands-on clinical application, ensuring that innovations are not only scientifically sound but also feasible for real-world implementation, including in low-resource healthcare systems.

Research Skills

Dr. Cvetkovic possesses a wide range of research and educational skills, integrating clinical expertise with advanced training methodologies. She is proficient in simulation-based research, designing and leading large-scale multidisciplinary training programmes for paediatric cardiac and intensive care teams. Her skills include curriculum development, virtual and augmented reality integration, and educational platform creation (e.g., MIRACCLE). She is experienced in ECMO education, paediatric transoesophageal echocardiography (TOE) training, and developing specialised protocols for perioperative care and cardiac ICU management. She has contributed to international conference workshops, peer-reviewed publications, and collaborative research studies in Scopus and other indexed journals. Her humanitarian project skills include capacity-building strategies, protocol standardisation, and team-training in low-resource settings. She is adept at using structured educational tools like the WHO Surgical Safety Checklist, SAFE communication, and SCAMPs. Dr. Cvetkovic’s ability to combine clinical precision with innovative teaching techniques makes her a highly effective research leader and educator, capable of translating complex clinical concepts into practical, scalable solutions.

Awards and Honours

Dr. Cvetkovic has earned recognition for her exceptional contributions to paediatric cardiac anaesthesia, intensive care, and medical simulation on both national and international platforms. As a EuroELSO Scientific Committee Member, she has influenced the global ECMO education agenda and been invited to lead major simulation-based workshops at EuroELSO, ESPNIC, and EAPS conferences. She has received formal commendations for her humanitarian work in Africa and Asia, where her leadership in establishing sustainable paediatric cardiac units has had lasting health impacts. Her role as an Honorary Lecturer at University College London acknowledges her academic influence, while invitations to deliver lectures and training across Europe, the Middle East, Asia, and Africa demonstrate her global standing. Certification as an Advanced Medical Simulation Instructor by Harvard University and the University of Copenhagen further underscores her excellence in clinical education. She is an active member of leading professional societies including ESPA, SPA, EACTA, SCA, AMEE, IPSS, ESPNIC, DASAIM, and PICS, reflecting her respected status in the field. Her career achievements reflect not only her clinical expertise but also her dedication to global health education and research innovation.

Publication Top Notes

  • “Bridging Europe” advancing Education: The 12th Educational Corner at EuroELSO 2024 conference in Krakow, Poland — 2025

  • “Bridging the Gap” international ECLS training and simulation – evaluation of the 10th educational corner on EuroELSO congress 2022 in London, United Kingdom — 2023

  • Clinical Guidelines for Routine Neuromonitoring in Neonatal and Pediatric Patients Supported on Extracorporeal Membrane Oxygenation — 2023

  • Long-Term Quality of Life in Congenital Heart Disease Surgical Survivors: Multicenter Retrospective Study of Surgical and ICU Explanatory Factors — 2023

  • Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension in a 5-year-old Girl with No Risk Factors — 2022

  • Results of EuroELSO Neurological Monitoring and Neurodevelopmental Outcome Survey — 2021

  • Challenges in Paediatric Cardiac Anaesthesia in Developing Countries — 2018

  • Comparison of Early Outcomes for Normothermic and Hypothermic Cardiopulmonary Bypass in Children Undergoing Congenital Heart Surgery — 2018

  • Brain monitoring in adult and paediatric ECMO patients: the importance of early and late assessments — 2017

  • Real-life use of vasopressors and inotropes in cardiogenic shock-observation is necessarily ‘theory-laden’ — 2016

Conclusion

Dr. Mirjana Cvetkovic is a distinguished clinician, educator, and researcher whose work has transformed paediatric cardiac anaesthesia and intensive care practices worldwide. At Great Ormond Street Hospital, she combines high-level clinical expertise with pioneering educational initiatives that have set new benchmarks in simulation-based medical training. Her MIRACCLE platform and advanced multidisciplinary programmes have significantly improved knowledge exchange in cardiothoracic care. Beyond her institutional role, her humanitarian missions have established sustainable paediatric cardiac services in resource-limited settings, directly impacting countless young lives. Her research seamlessly integrates innovative technologies such as virtual reality and 3D printing with real-world clinical application, contributing to safer, more efficient care pathways. Actively engaged in global collaborations, she influences medical education and practice at an international scale. With her combination of technical skill, academic leadership, and humanitarian dedication, Dr. Cvetkovic exemplifies the qualities of a world-class medical professional and is exceptionally deserving of recognition for her contributions to health professions research and service.

Farid Badria | Health Professions | Best Researcher Award

Published on by WSA Awards

Prof. Dr. Farid Badria | Health Professions | Best Researcher Award

Mansoura University, Egypt

Dr. Farid A. Badria is a distinguished Professor of Pharmacognosy at the Faculty of Pharmacy, Mansoura University, Egypt, where he also leads the Liver Research Lab (FAB-Lab). With a career spanning over three decades, he has emerged as a leading expert in natural products research, biomedical sciences, and translational medicine. His research portfolio encompasses phytochemistry, biotechnology, drug discovery, liver diseases, and diagnostic biomarker development. A globally recognized scholar, Dr. Badria’s academic contributions have earned him several prestigious awards, including recognition by Stanford University among the top 2% most-cited scientists in his field. He has held visiting positions at top institutions such as the University of Minnesota and University of Mainz, Germany. His work bridges academia and practical applications by emphasizing sustainable drug development from natural sources, making his research relevant both scientifically and industrially. In addition to his prolific publication record and extensive teaching responsibilities, Dr. Badria has played significant roles in academic governance and research ethics in Egypt. He is a member of multiple scientific organizations and has mentored numerous students and researchers. His commitment to scientific excellence, public health, and academic leadership makes him a worthy contender for the Best Researcher Award.

Professional Profile

Education

Dr. Badria’s educational background reflects his deep expertise in pharmacognosy, cell biology, and natural product chemistry. He holds a Ph.D. in Microbial Transformations and Natural Products Chemistry from the University of Mississippi, USA, where he conducted groundbreaking research on microbial metabolism and structural elucidation of bioactive compounds. Prior to this, he earned a Master of Science in Pharmaceutical Cell Biology and Natural Toxins from the University of Minnesota, USA. His early graduate education also includes an M.Sc. in Pharmacognosy and Natural Products Chemistry from Mansoura University, Egypt, where he began his career as a dedicated researcher. Dr. Badria earned his undergraduate degree, a B.Sc. in Pharmaceutical Sciences, from the same institution. His rigorous academic training in both Egypt and the United States provided him with a comprehensive foundation in natural sciences, advanced analytical techniques, pharmacology, and biotechnology. This diverse and multidisciplinary academic formation has empowered him to investigate complex biomedical problems, develop novel therapeutic strategies, and mentor future generations of scientists in both theoretical and applied pharmaceutical sciences. His global educational experience has also facilitated international collaboration and innovation throughout his career.

Professional Experience

Dr. Farid A. Badria has amassed extensive academic and professional experience, serving in various esteemed roles that have shaped pharmaceutical education and research in Egypt and abroad. At Mansoura University, he has held positions ranging from Assistant Professor (1990) to Full Professor (since 2000), and has served as Head of the Pharmacognosy Department, Head of Applied Drug Research, and Director of the Central Research Lab. As the founding head of the Liver Research Lab (FAB-Lab), he has led pioneering work on liver disorders, natural enzyme modulators, and phytotherapy. His international career includes Visiting Professorships in Medicinal Chemistry at the University of Minnesota (USA) and at Universität Mainz (Germany), where he contributed to research on marine-derived drugs, apoptosis, and biomarkers. He has also served as a consultant and research associate in the United States. Additionally, Dr. Badria has actively contributed to academic governance, including roles on the Supreme Pharmacy Council of Egypt, Clinical Pharmacy Program Committee, and Promotion Committee for Pharmacy Professors. His professional journey reflects a harmonious blend of research innovation, academic leadership, and societal impact. His contributions have not only enriched his institutions but also advanced pharmaceutical sciences at the global level.

Research Interest

Dr. Badria’s research interests are interdisciplinary and pioneering, integrating natural product chemistry, biotechnology, pharmacognosy, and modern therapeutic strategies. His major focus lies in identifying novel bioactive compounds from plants, marine organisms, and microbial sources for use in drug discovery and disease treatment. A core area of his research targets liver diseases, particularly fibrosis and hepatocellular carcinoma, using hepatoselective agents and early diagnostic biomarkers. He is also deeply involved in phytotherapy for skin and metabolic disorders, such as alopecia, hyperpigmentation, obesity, and diabetes, through the modulation of key enzymes like aldose reductase and glucosidase. Additionally, Dr. Badria has worked extensively on cancer diagnostics (particularly ovarian and liver cancer), retinal pathology, and viral infections using both biochemical and AI-based models. His work explores enzyme inhibition as a central therapeutic mechanism and includes studies on topoisomerase, tyrosinase, and hyaluronidase inhibitors. His holistic approach also extends to environmental research, where he has developed biomarkers to monitor marine and freshwater pollution. Overall, Dr. Badria’s research combines traditional natural medicine with cutting-edge biomedical technologies, positioning him at the forefront of translational pharmacognosy and integrative therapeutic sciences.

Research Skills

Dr. Badria possesses a comprehensive and advanced skill set in both laboratory and clinical research methodologies. His expertise in natural products chemistry is demonstrated through his extensive use of chromatographic and spectroscopic techniques (HPLC, NMR, MS, IR, UV) to isolate and characterize novel therapeutic compounds. He is highly skilled in microbial transformation, tissue culture, and biological screening assays for evaluating cytotoxicity, antiviral activity, and enzyme inhibition. His work with mammalian cell culture, tumor induction, cryogenic preservation, and plant tissue cloning reflects his deep command over pharmaceutical biotechnology. Dr. Badria also utilizes AI and computational tools in healthcare research for predictive modeling in liver cancer, obesity, and treatment decision-making. His knowledge of biomarker discovery is applied in both clinical diagnostics and environmental science, identifying indicators for diseases and pollutants in human and aquatic systems. He is adept at experimental design, pharmacological evaluation, and interdisciplinary collaboration. These skills enable him to translate theoretical insights into practical applications, particularly in liver disease therapy, cancer detection, and anti-inflammatory drug development. Dr. Badria’s methodological rigor and technical proficiency are key strengths that drive the success and innovation of his research programs.

Awards and Honors

Dr. Badria’s exceptional research achievements have been recognized with numerous prestigious awards and honors, both nationally and internationally. Most notably, he was cited by Stanford University among the top 2% most-cited scientists in Medicinal and Biomolecular Chemistry. He received the World Intellectual Property Organization (WIPO) Gold Medal in 2011 as the “Best Inventor in Egypt,” and the Third World Academy of Sciences (TWAS) Prize in 2013 for public science communication. His national accolades include multiple State Recognition Awards in Medicine from the Egyptian Academy of Science and Merit of First Class from the President of Egypt in 1998. Internationally, he was honored with the Khawarizmi International Award (Iran, 2000), the NAM S&T Fellowship, and fellowships from UNESCO and the Arab Development Fund. Dr. Badria is also a member of several elite scientific bodies including the American Association for the Advancement of Science (AAAS), New York Academy of Sciences, and the American Society of Pharmacognosy (ASP). These accolades highlight not only his research excellence but also his contributions to science policy, innovation, and knowledge dissemination across borders.

Conclusion

In conclusion, Dr. Farid A. Badria exemplifies the qualities of an outstanding researcher whose work transcends disciplinary boundaries and geographic limitations. His career is characterized by an unwavering commitment to scientific advancement, innovation in natural products research, and impactful contributions to public health, particularly in liver disease treatment and diagnostics. Through his leadership in research, education, and institutional development, he has significantly elevated the scientific standing of Mansoura University and Egypt at large. His global engagements, collaborative initiatives, and mentoring have further amplified the reach and relevance of his work. Dr. Badria’s legacy is built not only on his prolific academic output and technical expertise but also on his dedication to integrating traditional medicine with modern science for the betterment of human health. Given his comprehensive and influential body of work, he is undoubtedly a highly suitable candidate for the Best Researcher Award, representing the highest standards of research integrity, innovation, and social responsibility in the scientific community.

Publications Top Notes

  • Synthesis and biological evaluation of certain α, β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents
    Authors: HI El-Subbagh, SM Abu-Zaid, MA Mahran, FA Badria, AM Al-Obaid
    Journal: Journal of Medicinal Chemistry 43(15), pp. 2915–2921, 2000
    Citations: 536

  • Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles
    Authors: S Bondock, S Adel, HA Etman, FA Badria
    Journal: European Journal of Medicinal Chemistry 48, pp. 192–199, 2012
    Citations: 266

  • Melatonin, serotonin, and tryptamine in some Egyptian food and medicinal plants
    Author: FA Badria
    Journal: Journal of Medicinal Food 5(3), pp. 153–157, 2002
    Citations: 266

  • Antioxidant and immunomodulatory constituents of henna leaves
    Authors: BR Mikhaeil, FA Badria, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 59(7–8), pp. 468–476, 2004
    Citations: 265

  • Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as antioxidant, anti-inflammatory and analgesic activities
    Authors: ABA El-Gazzar, MM Youssef, AMS Youssef, AA Abu-Hashem, FA Badria
    Journal: European Journal of Medicinal Chemistry 44(2), pp. 609–624, 2009
    Citations: 236

  • Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles
    Authors: BF Abdel-Wahab, GEA Awad, FA Badria
    Journal: European Journal of Medicinal Chemistry 46(5), pp. 1505–1511, 2011
    Citations: 212

  • Synthesis of some new pyrimido[2′,1′:2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents
    Authors: AA Abu-Hashem, MA Gouda, FA Badria
    Journal: European Journal of Medicinal Chemistry 45(5), pp. 1976–1981, 2010
    Citations: 212

  • Natural products for dental caries prevention
    Authors: FA Badria, OA Zidan
    Journal: Journal of Medicinal Food 7(3), pp. 381–384, 2004
    Citations: 189

  • Chemistry and immunomodulatory activity of frankincense oil
    Authors: BR Mikhaeil, GT Maatooq, FA Badria, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(3–4), pp. 230–238, 2003
    Citations: 179

  • Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood
    Authors: FA Badria, BR Mikhaeil, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(7–8), pp. 505–516, 2003
    Citations: 165

Willi Tarver | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Willi Tarver | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Ohio State University, United States

Dr. Willi L. Tarver is a distinguished Assistant Professor in the Division of Cancer Prevention and Control at The Ohio State University, where he leverages his interdisciplinary expertise to address disparities in healthcare delivery and cancer outcomes. With a strong foundation in public health informatics, behavioral oncology, and medical library sciences, Dr. Tarver’s research focuses on integrating patient-reported outcomes (PROs), electronic tools, and equity-focused interventions to better engage underserved populations in the cancer care continuum. His professional trajectory includes advanced fellowships in behavioral oncology and medical informatics, and he is actively involved in federally funded research projects. Dr. Tarver is also deeply committed to mentoring students and early-career professionals, especially from underrepresented backgrounds. His scholarly work addresses systemic issues in healthcare access and aims to develop scalable, tech-based strategies to reduce disparities. In addition to research and teaching, he plays key roles in administrative and clinical improvement initiatives within OSU’s Quality Improvement Hub. Dr. Tarver’s growing leadership within national organizations, innovative approach to equitable cancer prevention, and consistent focus on translating research into real-world applications position him as a leader in academic medicine and public health. He is a compelling nominee for the Best Researcher Award.

Professional Profile

Education

Dr. Tarver’s educational background reflects a unique and valuable combination of public health, information science, and communication, which together form the backbone of his interdisciplinary research. He earned his Doctor of Public Health (Dr.P.H.) from the University of Alabama at Birmingham, where he was also a recipient of the prestigious NCI Diversity Supplement under the Cancer Prevention and Control Training Program. Prior to this, he completed dual Master’s degrees in Public Health (MPH) and Library and Information Science (MLIS) at the University of South Florida. His foundational undergraduate training includes a B.A. in Communication from Columbus State University and an A.S. in Pre-Pharmacy from Gordon College. Dr. Tarver further sharpened his expertise through two postdoctoral fellowships: one in Behavioral Oncology at Indiana University and another in Medical Informatics at the VA Medical Center in Indianapolis. These fellowships provided him with advanced training in clinical research, data analytics, and healthcare system improvement. His broad and deep academic background allows him to bridge clinical research, informatics, and patient-centered interventions—a combination that has enabled his innovative work in cancer disparities and technology-enhanced health solutions.

Professional Experience

Dr. Tarver’s professional journey is defined by a blend of academic, clinical, and administrative roles that support his contributions to cancer prevention, health equity, and public health informatics. Currently serving as an Assistant Professor in the Division of Cancer Prevention and Control within the Department of Internal Medicine at The Ohio State University, he has held this role since 2019. Prior to this appointment, he was a postdoctoral and informatics fellow at the Roudebush VA Medical Center and Indiana University–Purdue University Indianapolis. During his time at the VA, Dr. Tarver contributed to the Center for Health Information and Communication, refining his expertise in applying informatics to support equitable healthcare delivery. His professional roles also extend into quality improvement, where he co-led the Health Equity Core at OSU’s Quality Improvement Hub from 2022 to 2024. Dr. Tarver is an active mentor in OSU’s Center for Cancer Health Equity Summer Research Program, guiding underrepresented students in impactful, community-focused projects. In addition, he participates in institutional governance as a member of OSU’s Innovation Council. Across his roles, he has demonstrated consistent leadership, interdisciplinary collaboration, and a deep commitment to improving health outcomes through equitable and data-driven approaches.

Research Interests

Dr. Tarver’s research is driven by a deep commitment to eliminating disparities in cancer prevention and control through the integration of technology, public health, and clinical practice. His primary interest lies in the development and evaluation of patient-centered technologies—particularly electronic patient-reported outcomes (ePRO) tools—to better engage underserved populations and inform health system decision-making. His projects explore how these tools can be tailored to the unique needs of minority communities, improve cancer survivorship planning, and enhance real-time communication between patients and providers. Another major area of interest is health equity, where Dr. Tarver investigates the impact of perceived discrimination, systemic biases, and cultural barriers on cancer care utilization and outcomes. Additionally, he is involved in research that evaluates educational interventions designed to reduce STEM-related biases in high school learning environments. Through his interdisciplinary work, Dr. Tarver aims to generate actionable insights that not only contribute to academic knowledge but also guide policy reforms and clinical practices. His interests span behavioral oncology, implementation science, and medical informatics, positioning him at the forefront of translational research that impacts patient lives while advancing health equity on a systemic scale.

Research Skills

Dr. Tarver possesses a robust skill set in both qualitative and quantitative research methodologies, which he applies to projects at the intersection of health equity, informatics, and cancer prevention. He is highly experienced in designing and analyzing patient-reported outcomes (PROs), particularly within underserved and minority populations. His expertise includes conducting structured interviews, participant observation, and systematic reviews—skills he actively shares as a guest lecturer in OSU’s Public Health Informatics course. Dr. Tarver is also proficient in research related to intervention development and evaluation, including randomized trials and implementation science frameworks. His grant-writing capabilities are demonstrated by his role as Principal Investigator (PI) and Co-Investigator (Co-I) on several federal and institutional research awards. He collaborates across disciplines, including clinical medicine, education, behavioral science, and information systems, to build comprehensive research designs. Additionally, he has applied informatics tools for data visualization, regulatory decision-making, and game-based learning assessments. These skills empower him to execute complex, multilevel projects with real-world applicability and high translational value. His research toolkit is complemented by strong mentorship abilities, fostering new talent and promoting equity-focused research within academic and clinical settings.

Awards and Honors

Dr. Tarver has received multiple prestigious honors that reflect his academic excellence, research promise, and commitment to advancing health equity. He was honored with the Young Investigator Award at the VA Medical Center in Indianapolis, recognizing his early-career contributions to cancer prevention research. His selection for the VA Advanced Fellowship in Medical Informatics further highlights his potential as a leader in data-driven health solutions. As a fellow in Behavioral Oncology at Indiana University, he gained national recognition for his work integrating psychological, behavioral, and technological approaches to patient-centered care. Notably, he was a recipient of the Diversity Supplement from the National Cancer Institute (NCI) through the University of Alabama at Birmingham, affirming his focus on minority health and health disparities. Earlier in his academic journey, he was awarded the ALSTARS Scholarship at the University of South Florida for academic merit and leadership. These accolades not only reflect his dedication to research excellence but also underscore the national recognition he has received for addressing some of the most pressing challenges in health equity, cancer care, and public health education.

Conclusion

In conclusion, Dr. Willi L. Tarver stands out as an exceptionally well-rounded and impactful academic professional whose contributions significantly advance the fields of cancer prevention, public health informatics, and health equity. His ability to bridge research, mentorship, education, and clinical innovation uniquely qualifies him for the Best Researcher Award. Through interdisciplinary training, funded research projects, and active mentorship, Dr. Tarver continues to address real-world health disparities and improve patient outcomes, particularly in underserved communities. His track record as a Principal Investigator and collaborator on diverse research grants highlights his leadership and collaborative capabilities. Moreover, his mentorship of minority students and involvement in institutional quality improvement initiatives reflect a long-term investment in both people and systems. With a growing portfolio of honors, active society memberships, and educational contributions, Dr. Tarver is positioned for continued excellence and recognition in the academic and public health communities. His work exemplifies the values of translational research, social impact, and scientific integrity, making him a deserving and distinguished candidate for the Best Researcher Award.

Publications Top Notes

1. Family structure and risk behaviors: the role of the family meal in assessing likelihood of adolescent risk behaviors
📅 Year: 2014
✍️ Authors: S. Goldfarb, W.L. Tarver, B. Sen
📰 Psychology Research and Behavior Management, pp. 53–66
📈 Citations: 83

2. The use of cancer-specific patient-centered technologies among underserved populations in the United States: systematic review
📅 Year: 2019
✍️ Authors: W.L. Tarver, D.A. Haggstrom
📰 Journal of Medical Internet Research, 21(4), e10256
📈 Citations: 68

3. Growth dynamics of patient-provider internet communication: trend analysis using the Health Information National Trends Survey (2003 to 2013)
📅 Year: 2018
✍️ Authors: W.L. Tarver, T. Menser, B.W. Hesse, T.J. Johnson, E. Beckjord, E.W. Ford, et al.
📰 Journal of Medical Internet Research, 20(3), e109
📈 Citations: 56

4. A systematic review of the association between family meals and adolescent risk outcomes
📅 Year: 2015
✍️ Authors: S.S. Goldfarb, W.L. Tarver, J.L. Locher, J. Preskitt, B. Sen
📰 Journal of Adolescence, 44, pp. 134–149
📈 Citations: 56

5. Exploring disparities and variability in perceptions and self-reported colorectal cancer screening among three ethnic subgroups of US Blacks
📅 Year: 2010
✍️ Authors: C.K. Gwede, C.M. William, K.B. Thomas, W.L. Tarver, G.P. Quinn, et al.
📰 Oncology Nursing Forum, 37(5), 581
📈 Citations: 51

6. A randomized trial to compare a tailored web-based intervention and tailored phone counseling to usual care for increasing colorectal cancer screening
📅 Year: 2018
✍️ Authors: V.L. Champion, S.M. Christy, W. Rakowski, W.G. Gathirua-Mwangi, W.L. Tarver, et al.
📰 Cancer Epidemiology, Biomarkers & Prevention, 27(12), 1433–1441
📈 Citations: 35

7. The impact of health information technology on cancer care across the continuum: a systematic review and meta-analysis
📅 Year: 2016
✍️ Authors: W.L. Tarver, N. Menachemi
📰 Journal of the American Medical Informatics Association, 23(2), 420–427
📈 Citations: 35

8. Perceptions of colorectal cancer among three ethnic subgroups of US blacks: a qualitative study
📅 Year: 2011
✍️ Authors: C.K. Gwede, E. Jean-Francois, G.P. Quinn, S. Wilson, W.L. Tarver, K.B. Thomas, et al.
📰 Journal of the National Medical Association, 103(8), 669–680
📈 Citations: 35

9. Allostatic load: a framework to understand breast cancer outcomes in Black women
📅 Year: 2021
✍️ Authors: S. Obeng-Gyasi, W. Tarver, R.C. Carlos, B.L. Andersen
📰 NPJ Breast Cancer, 7(1), 100
📈 Citations: 34

10. Factors associated with adherence to mammography screening among insured women differ by income levels
📅 Year: 2018
✍️ Authors: W. Gathirua-Mwangi, A. Cohee, W.L. Tarver, A. Marley, E. Biederman, et al.
📰 Women’s Health Issues, 28(5), 462–469
📈 Citations: 34

Yana Zhang | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Assoc. Prof. Dr. Yana Zhang | Medicine and Dentistry | Best Researcher Award

Associate Professor from Department of Otolaryngology-Head and Neck Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

Dr. Yana Zhang is an accomplished academic and researcher in the field of Otorhinolaryngology–Head and Neck Surgery, currently serving as an Associate Professor at the Third Affiliated Hospital of Sun Yat-sen University. She holds a Ph.D. from Tongji Medical College, Huazhong University of Science and Technology, China, and has completed a postdoctoral fellowship at Northwestern University, USA. With over a decade of research and clinical experience, Dr. Zhang has established herself as a leading figure in allergy and airway inflammation research. Since joining Sun Yat-sen University through the prestigious “Hundred Talents Program” in 2020, she has been spearheading multiple high-impact research projects. She has published more than 40 peer-reviewed articles in journals such as Nature Immunology, J Allergy Clin Immunol, J Exp Med, and Am J Respir Crit Care Med, many as first or corresponding author. Her research focuses on the molecular mechanisms underlying allergic inflammation and chronic rhinosinusitis. Dr. Zhang plays influential roles in several national academic and medical committees and is a regular reviewer for high-impact journals and research foundations. Her work is recognized for its translational value, aiming to improve treatment outcomes for patients with allergic diseases and ENT disorders.

Professional Profile

Education

Dr. Yana Zhang pursued her higher education in medicine and specialized in Otorhinolaryngology–Head and Neck Surgery. She earned her Ph.D. from Tongji Medical College at Huazhong University of Science and Technology in 2014, one of China’s most respected institutions in medical research. Her doctoral work focused on immunological mechanisms and inflammatory processes in chronic rhinosinusitis and other airway-related disorders, laying the groundwork for her later research. She subsequently enhanced her academic portfolio by undertaking postdoctoral training at Northwestern University in the United States from 2016 to 2020. This international experience enabled her to refine her research methods and establish collaborations with world-renowned immunologists and clinical scientists. Her training at Northwestern offered her exposure to advanced biomedical research techniques and allowed her to integrate global best practices into her work. This comprehensive academic background has provided her with a solid foundation to pursue advanced research in translational medicine, particularly in immune-mediated diseases of the upper respiratory tract. Her education reflects a blend of rigorous Chinese medical training and cutting-edge international research exposure, positioning her as a global scholar with a deep understanding of both clinical and experimental approaches.

Professional Experience

Dr. Zhang began her professional academic career after completing her Ph.D. in 2014. Following this, she undertook a postdoctoral fellowship at Northwestern University in the United States from 2016 to 2020, where she worked on translational research projects focused on immunoregulation and inflammatory diseases. This experience significantly expanded her research expertise and network. In 2020, she returned to China to join the Third Affiliated Hospital of Sun Yat-sen University as an Associate Professor through the university’s highly competitive “Hundred Talents Program.” In this role, she leads a dynamic research team working on inflammatory mechanisms in chronic rhinosinusitis and allergy-related comorbidities. Dr. Zhang also holds several influential academic appointments, including expert reviewer roles for the Ministry of Education and the National Natural Science Foundation of China. She serves on various national committees under the Chinese Medical Association and other professional bodies, contributing to policy, research direction, and academic evaluations. She also plays a key role in mentoring graduate students and guiding young researchers. Her multidisciplinary experience bridges clinical practice and molecular science, allowing her to translate laboratory findings into potential therapies for ENT and allergic conditions.

Research Interests

Dr. Yana Zhang’s research centers on immunological mechanisms and therapeutic strategies targeting eosinophilic inflammation and allergic airway diseases. Her work addresses chronic rhinosinusitis with nasal polyps (CRSwNP), a debilitating and recurring inflammatory disorder, and aims to unravel the molecular underpinnings of steroid resistance and epithelial barrier dysfunction. She has explored novel pathways involving fatty acids, IL-17A, vitamin D, and extracellular vesicles in allergic disease models. Her recent studies investigate the roles of epithelium-derived chemokines, Charcot-Leyden crystals, and immune checkpoints in modulating inflammation and tissue remodeling. Another central focus of her research is the interaction between environmental factors, such as air pollution, and the immunopathology of rhinitis and asthma. Dr. Zhang’s goal is to translate her laboratory findings into effective therapeutic strategies that can be applied in clinical settings. Her research also spans the field of immune metabolism, including succinate signaling and its effect on regulatory T cells, with implications for systemic autoimmune and allergic diseases. Her interdisciplinary work combines molecular biology, clinical otorhinolaryngology, and immunotherapy to address urgent healthcare challenges in allergy and airway inflammation.

Research Skills

Dr. Zhang is equipped with a comprehensive skill set in both clinical and molecular research. Her expertise includes cellular immunology, molecular biology, transcriptomics, histopathology, and translational medicine. She is proficient in designing and conducting in vivo and in vitro models of airway inflammation, including murine models of eosinophilic rhinosinusitis. She has extensive experience in flow cytometry, ELISA, immunohistochemistry, RNA sequencing, confocal microscopy, and CRISPR-Cas9 gene editing technologies. Her postdoctoral training at Northwestern University further enhanced her proficiency in advanced immunological assays, including Treg stability assays, metabolite analysis, and cell differentiation studies. Dr. Zhang is skilled in developing predictive models and statistical algorithms to interpret clinical outcomes and endotypes in allergic patients. Additionally, she collaborates with bioinformatics experts to analyze large datasets, facilitating biomarker discovery and patient stratification. Her capacity to bridge bench-side experimentation with clinical relevance makes her a leader in translational allergy research. Dr. Zhang’s multidisciplinary research environment allows her to apply both clinical acumen and lab-based expertise to uncover new therapeutic avenues in chronic inflammatory diseases.

Awards and Honors

Dr. Yana Zhang has received multiple accolades that reflect her scholarly excellence and leadership in biomedical research. Most notably, she was selected as a Young Top Talent under the Guangdong “Pearl River Talent Program” in 2022, a prestigious recognition for emerging scientific leaders in China. In 2020, she was recruited through the “Hundred Talents Program” at Sun Yat-sen University, a national initiative to attract top researchers to Chinese academic institutions. These honors underscore her scientific impact and potential to contribute to national innovation goals. In addition to these major recognitions, Dr. Zhang has been invited to serve as a grant reviewer for the National Natural Science Foundation of China, a testament to her credibility and leadership in the scientific community. She is also an expert evaluator for doctoral dissertations under the Ministry of Education. Her editorial and peer-review responsibilities for internationally reputed journals further reflect her standing in the academic field. Collectively, these awards and responsibilities highlight her commitment to advancing research, mentoring junior scientists, and shaping the future of otorhinolaryngology and immunology in China and beyond.

Conclusion

Dr. Yana Zhang stands out as an exceptional researcher and academic whose work has had a profound impact on the field of immunology and otorhinolaryngology. Her career reflects a harmonious blend of rigorous academic training, international experience, and a deep commitment to translational medicine. Through cutting-edge research on eosinophilic inflammation and allergic diseases, she has significantly advanced our understanding of the pathophysiological mechanisms underlying chronic airway disorders. Her contributions are well-documented through a robust portfolio of publications in top-tier scientific journals and her leadership in multiple national research projects. Furthermore, her active involvement in academic societies and committees showcases her dedication to the scientific community. Dr. Zhang’s efforts not only enhance clinical outcomes for patients but also influence national policy and research directions. Her vision of integrating basic research with clinical application makes her a key figure in developing personalized treatments for allergy and ENT disorders. With continued support and collaboration, Dr. Zhang is poised to make even greater strides in medical science and to serve as a role model for future researchers in China and globally.

Publications Top Notes

  1. Vitamin D impedes eosinophil chemotaxis via inhibiting glycolysis‑induced CCL26 expression in eosinophilic chronic rhinosinusitis with nasal polyps

  • Year: 2025

  • Authors: Weiqiang Huang, Yana Zhang, Yue Li, Junming Ma, Xia Li, Yanjie Jiang, Jianqi Wang, Haotian Wu, Xiaohong Chen, Zizhen Huang, Xifu Wu, Xiaoping Lai, Donglin Li, Lihong Chang, Gehua Zhang

2. Succinate drives gut inflammation by promoting FOXP3 degradation through a molecular switch

  • Year: 2025

  • Authors: Hai Wang, Danqing Hu, Yang Cheng, Qiong Gao, Kun Liu, Nikita L. Mani, Amy Y. Tang, Radhika Iyer, Beixue Gao, Leyu Sun, Qi Zhou, Qin Yu, Samuel E. Weinberg, Xiaoyu Zhang, Yingzi Cong, Parambir S. Dulai, Yana Zhang, Zheng Liu, Deyu Fang

 

 

Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Professor, Dept Of Oncopathology from Mahamana Pandit Madan Mohan Malviya Cancer Centre (Tata Memorial Hospital) Varanasi, India

Dr. Zachariah Chowdhury is an accomplished academician, clinician, and researcher in the field of oncopathology, currently serving as the Professor and Officer-in-Charge of the Department of OncoPathology at the Mahamana Pandit Madan Mohan Malaviya Cancer Centre (MPMMCC) & Homi Bhabha Cancer Hospital (HBCH) in Varanasi, under the Tata Memorial Centre. With foundational training in MBBS and MD in Pathology from Assam Medical College and a UICC Fellowship in Oncopathology, he has demonstrated an unwavering commitment to excellence in pathology and cancer diagnostics. His extensive teaching background includes instruction at multiple academic levels, including DM, MD, MBBS, nursing, and laboratory technology programs. Dr. Chowdhury has amassed an impressive portfolio of over 50 peer-reviewed publications, addressing both common and rare oncological conditions, contributing significantly to the evolving understanding of oncopathology. He is recognized for his comprehensive approach that merges histopathology, cytopathology, hematopathology, and molecular pathology. As a reviewer, invited speaker, and research presenter at both national and international platforms, he exemplifies the qualities of a dedicated and visionary medical researcher. His contributions to both clinical practice and research make him a pivotal figure in the Indian medical community and a strong candidate for national and international honors in the field of cancer pathology.

Professional Profile

Education

Dr. Chowdhury’s academic journey began with outstanding scholastic achievements, securing the 5th rank in his Higher Secondary School Examination from Cotton College, Guwahati, with a remarkable 83.6% score. He earned his MBBS from Assam Medical College under Dibrugarh University in 2004, ranking 2nd in his final examinations. His dedication to medical sciences continued with an MD in Pathology in 2011 from the same institution, where he again demonstrated academic excellence by clearing all examinations in his first attempt. Complementing his postgraduate training, Dr. Chowdhury was awarded the prestigious UICC/Dr. Praful Desai Fellowship in Oncopathology at Tata Memorial Centre, Mumbai, where he further honed his expertise in histopathology, cytopathology, and molecular diagnostics. Additionally, he underwent advanced training in molecular pathology at Tata Medical Centre, Kolkata, and Tata Memorial Centre, Parel, reinforcing his foundation in modern cancer diagnostics. His academic credentials are supported by multiple merit certificates from the Assam Higher Secondary Education Council, All Assam Students Union, and Assam Medical College, highlighting consistent academic distinction from secondary education through to his postgraduate years. This strong educational foundation has enabled Dr. Chowdhury to effectively lead both clinical and academic responsibilities in the field of oncopathology.

Professional Experience

Dr. Zachariah Chowdhury has accumulated rich and diverse professional experience across multiple prestigious institutions. He began his teaching career as a Senior Resident Doctor at the North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, where he served for three years post-MD, laying a strong foundation in clinical pathology and academic instruction. Currently, he serves as Professor and Officer-in-Charge of the Department of OncoPathology at MPMMCC & HBCH in Varanasi, both units under the Tata Memorial Centre. In this leadership role, he oversees academic training and diagnostic services in a high-volume cancer care setting. Dr. Chowdhury’s responsibilities include teaching DM (OncoPathology), MD (Pathology), MBBS, nursing, and laboratory science students in both theory and laboratory environments. His clinical expertise encompasses a wide spectrum, including histopathology, cytopathology, hematopathology, molecular diagnostics, clinical pathology, renal pathology, immunopathology, and blood banking. Additionally, he plays an active role in quality assurance programs within the diagnostic laboratory. Beyond his hospital commitments, he contributes to academia as a peer reviewer for multiple reputed medical journals and participates in national and international conferences as a speaker, panelist, and faculty. This blend of academic, clinical, and leadership experience underscores his stature as a seasoned medical professional.

Research Interest

Dr. Chowdhury’s research interests center around oncopathology with a multidisciplinary focus that integrates histopathology, molecular pathology, cytopathology, and hematopathology. His scholarly work investigates a wide range of oncological conditions, including breast cancer, thyroid lesions, ovarian tumors, pediatric malignancies, head and neck cancers, and hematolymphoid neoplasms. A key area of his research explores the diagnostic challenges and spectrum of rare tumors such as salivary gland neoplasms, solitary fibrous tumors, and angiosarcomas, with a special emphasis on cytohistological correlations and immunomorphological profiling. Additionally, he has contributed to understanding emerging themes like artificial intelligence in histopathology and the role of molecular diagnostics in rare malignancies. His recent studies include real-world clinical data on metastatic cancers and chemotherapy outcomes, bridging clinical practice with diagnostic research. Dr. Chowdhury’s commitment to evidence-based pathology is evident in his methodical approach to publishing both retrospective reviews and case-based literature, offering valuable insights to the global oncopathology community. His collaborations with multidisciplinary teams from oncology, radiology, and surgery reflect his integrative research philosophy. By focusing on both common diagnostic patterns and rare, underreported entities, his work not only advances academic pathology but also significantly contributes to clinical decision-making and patient outcomes.

Research Skills

Dr. Zachariah Chowdhury brings to the research landscape a comprehensive skill set encompassing classical and modern pathology techniques. He is proficient in histological examination, cytopathological evaluations (including FNAC and core biopsies), hematopathology analyses, and cutting-edge molecular diagnostics. His training at leading cancer centers like Tata Memorial Centre and Tata Medical Centre has equipped him with practical expertise in PCR, FISH, and immunohistochemistry techniques—essential tools in the molecular characterization of tumors. He also has expertise in immunomorphology and has applied these skills across a broad range of clinical cases, from pediatric cancers to high-grade lymphomas and soft tissue tumors. Dr. Chowdhury is also skilled in academic writing and statistical analysis, as evidenced by his extensive publication record across peer-reviewed indexed journals. His systematic approach to clinical audits, retrospective analyses, and diagnostic algorithm development further highlight his research rigor. Additionally, he has contributed to AI applications in cancer diagnosis, showcasing adaptability to new technologies. His experience in organizing research presentations and mentoring junior faculty and students also reflects strong leadership and team management skills within research settings. Altogether, his multidimensional research skills strongly align with the goals of translational oncology and precision medicine.

Awards and Honors

Dr. Chowdhury’s illustrious career has been recognized with numerous awards and honors, validating his significant impact in the field of pathology. Among the most notable are the Bharat Gaurav Puraskar (2023) and the Jewel of India Award (2024), both conferred by the KTK Outstanding Achievers and Education Foundation, New Delhi, for his exemplary contributions to pathology and medical education. During his academic years, he received multiple certificates of merit for academic excellence, including top ranks in both secondary and medical school examinations. His postgraduate performance earned him a Certificate of Merit from Assam Medical College. As a faculty member and researcher, he has consistently excelled in academic events, winning the first prize in Oral Paper Presentation at the 5th International Pediatric Pathology Conference (2022) and the Poster Presentation at NEIGRIHMS Annual Research Day (2018). His early career awards also include the North Eastern Council (NEC) Scholarship for MBBS, which supported his foundational medical education. Beyond these, his recognition extends to being a respected reviewer for multiple journals, and his frequent roles as invited speaker and panelist at various conferences. These accolades reflect both peer and institutional acknowledgment of his enduring impact on medical research and education.

Conclusion

Dr. Zachariah Chowdhury exemplifies the ideals of a clinician-scientist dedicated to excellence in oncopathology. With a firm grounding in both classical pathology and modern diagnostic innovations, he bridges the gap between histological diagnosis and translational cancer research. His career reflects a rare combination of clinical acumen, academic mentorship, research productivity, and institutional leadership. Through his prolific authorship of over 50 peer-reviewed publications, he contributes actively to the global understanding of complex and rare oncological entities. His commitment to education is evident in his multi-level teaching engagements and ongoing mentorship of pathology trainees. Dr. Chowdhury’s recognition through multiple national honors and academic awards further substantiates his role as a leading figure in cancer pathology in India. While already operating at a high level of academic and clinical distinction, future initiatives such as enhanced international collaborations, grant-funded research, and patent development would elevate his profile even further. Overall, Dr. Chowdhury represents a distinguished and highly qualified candidate for any recognition aimed at honoring pathologists and researchers who make substantial contributions to medical science, and particularly, to the evolving discipline of oncopathology.

Publications Top Notes

1. The many faces of ovarian sex cord stromal tumors: a clinicopathological analysis at a tertiary cancer center in North India

  • Year: 2025

  • Authors: Chowdhury Z, Agrawal S, Gupta S, Rai S, Jethani R, Saha S, Ranjan R, Pal A

  • Journal: Surgical and Experimental Pathology

2. The Myriad Spectrum of Salivary Gland Lesions: Cytohistological Correlation on Fine Needle Aspiration Cytology, Core Needle Biopsy, and Resections in a 5-Year Single Institutional Experience of North India

  • Year: 2025

  • Authors: Chowdhury Z, Majumdar P, Narain S, Lamba K

  • Journal: Diagnostic Cytopathology

3. ALK-positive large B-cell lymphoma: A study of six cases from an oncopathology center in North India

  • Year: 2025

  • Authors: Verma A, Chowdhury Z, Singh A, Kant A, Yadav A, Patne SCU

  • Journal: Indian Journal of Pathology and Microbiology

4. Cyto-Histomorphological Analysis of Thyroid Lesions and Risk Assessment of Malignancy/Neoplasia: Insights from a North Indian Tertiary Oncology Center

  • Year: 2025

  • Authors: Haiyat S, Chowdhury Z, Rudra Pal P, Patne S, Dhal I, Paul P

  • Journal: Cureus

5. An Analysis of Pediatric Round Cell Tumors Highlighting the Spectrum of Differential Diagnosis – A Single Center Experience and Systematic Review of Literature

  • Year: 2025

  • Authors: Dhal I, Lali BS, Rai H, Chowdhury Z, Patne S, Tripathi P, Saha S

  • Journal: International Journal of Scientific Studies

6. Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients

  • Year: 2025

  • Authors: Gupta A, Sansar B, Mishra BK, Khan A, Singh A, Upadhyay A, Chowdhury Z, Patne S, Tripathi M, et al.

  • Journal: Scientific Reports

7. Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)

  • Year: 2025

  • Authors: Kapoor A, Gupta A, Sansar B, Mishra BK, Gupta P, Singh A, Upadhyay A, Kashyap L, Pal A, Kumar A, Nanda SS, Mukherji A, Kapoor AR, Pradhan S, Mishra A, Chowdhury Z, Patne S, Dhal I, Singh N, et al.

  • Journal: JCO Global Oncology

8. Exploring Solitary Fibrous Tumors at a Tertiary Cancer Center: Clinicopathological and Immunomorphologic Profile

  • Year: 2024

  • Authors: Chowdhury Z, Mishrikotkar S, Nehra P, Patne S, Tripathi M

  • Journal: Cureus

9. A Review of the Applications of Artificial Intelligence in Histopathology

  • Year: 2024

  • Authors: Kandarpa S, Chowdhury Z, Pal PR, Rajput K, Saraf SA

  • Journal: Journal of Cancer Research Reviews & Reports

10. Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy

  • Year: 2024

  • Authors: Pujari L, Suresh A, Chowdhury Z, Pradhan S, Tripathi M, Gupta A, Singh P, Giridhar P, Kapoor AR, Shinghal A, Sansar B, Mv M

  • Journal: American Journal of Clinical Oncology

 

Risa Yamada | Health Professions | Best Researcher Award

Published on by WSA Awards

Ms. Risa Yamada | Health Professions | Best Researcher Award

Researcher from National Center of Neurology and Psychiatry, Japan

Risa Yamada is an esteemed Chief Researcher at the Department of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Japan. Her research primarily focuses on neuropsychopharmacology, epidemiology, and neurophysiology in patients with psychiatric disorders such as schizophrenia, mood disorders, and substance abuse. She is renowned for her pioneering work in the epidemiology of gambling disorders, exploring the impact of comorbid behavioral addiction. Her research has yielded significant insights into the effectiveness of serotonin-5-HT1A receptor partial agonists for cognitive enhancement in schizophrenia, with findings published in prestigious journals. Additionally, she is conducting cutting-edge research on transcranial photobiomodulation to ameliorate cognitive deficits in schizophrenia. Yamada has made notable contributions to the understanding of depression severity and the role of adverse childhood experiences in mood disorders. With a background in clinical psychology and neuropsychopharmacology, she is a rising leader in the field of psychiatric research.

Professional Profile

Education

Risa Yamada completed her medical education at the Jikei University School of Medicine, earning her Ph.D. in February 2023. Prior to this, she received a Bachelor of Science degree from Toho University in 2011 and a Master of Psychology from Teikyo University in 2018. Throughout her educational journey, she focused on the intersection of clinical psychology and psychiatry, particularly in understanding the neuropsychological aspects of psychiatric disorders. Her academic development laid a strong foundation for her subsequent research career. In addition to her medical degrees, Yamada holds certifications as a Clinical Psychologist (2019) and a Public Psychologist (2019), which further demonstrate her expertise and commitment to advancing psychological and psychiatric research. These educational qualifications, coupled with her practical research experience, allow Yamada to contribute significantly to the development of new treatment strategies for psychiatric conditions, particularly those related to cognitive dysfunction and behavioral addictions.

Professional Experience

Risa Yamada currently serves as the Chief Researcher at the Department of Preventive Intervention for Psychiatric Disorders at the National Institute of Mental Health, part of the National Center of Neurology and Psychiatry in Tokyo, Japan. She has been in this role since September 2021 and has been instrumental in leading research focused on cognitive impairments in psychiatric conditions such as schizophrenia. Yamada’s career began as a Research Associate in the Department of Mental Disorder Research at the National Center of Neurology and Psychiatry from 2018 to 2021, where she investigated depression severity and its links to adverse childhood experiences and coping styles. Prior to her current position, she conducted a doctoral research project at Jikei University, where she explored the relationship between gambling disorder and psychiatric conditions. Her extensive experience spans multiple research settings, with her work having a significant impact on clinical understanding and treatment development for various psychiatric conditions. Yamada’s role as a researcher and educator also extends to her involvement in several leading academic societies in psychiatry and neuropsychopharmacology.

Research Interests

Risa Yamada’s research interests lie at the intersection of clinical psychology, psychiatry, and neuropsychopharmacology. She is deeply engaged in studying the cognitive and neurophysiological aspects of psychiatric disorders, particularly schizophrenia, mood disorders, and behavioral addictions such as gambling disorders. Her work focuses on the use of neuropsychological methods to explore the biological and psychological underpinnings of these conditions, with a particular emphasis on cognitive impairment. One of her notable research projects involves studying the augmentation of cognitive function in schizophrenia using serotonin-5-HT1A receptor partial agonists, a promising avenue for improving psychotic symptoms and cognitive deficits. Additionally, Yamada is investigating the potential of transcranial photobiomodulation, a non-invasive brain stimulation technique, to address cognitive impairments in patients with schizophrenia. She also explores the relationship between adverse childhood experiences and mood disorders, with the goal of identifying effective biomarkers and treatments for negative valence in psychiatric conditions. Her research aims to advance both theoretical understanding and practical interventions for these prevalent and challenging mental health conditions.

Research Skills

Risa Yamada possesses a diverse and advanced skill set in clinical research, particularly in the fields of neuropsychopharmacology, epidemiology, and neurophysiology. She is proficient in conducting meta-analyses and cross-sectional studies, particularly related to psychiatric disorders and cognitive dysfunction. Her expertise in neuropsychological methods allows her to investigate complex interactions between psychological traits and psychiatric conditions. Yamada is skilled in using clinical scales and neurophysiological tools, such as skin conductivity measures, to assess psychological traits like interoception and alexithymia in relation to psychiatric conditions. Furthermore, she has experience in neuroimaging techniques, including the use of transcranial photobiomodulation for brain stimulation. Yamada’s work with behavioral addiction, particularly gambling disorders, demonstrates her ability to apply epidemiological methods to mental health research. She is also adept at analyzing large-scale clinical data sets and using statistical models to explore the relationship between psychiatric symptoms and demographic variables. These research skills enable her to lead impactful studies that contribute both to the scientific community and to practical applications in the treatment of psychiatric disorders.

Awards and Honors

Risa Yamada has received recognition for her contributions to psychiatric research, particularly in the areas of neuropsychopharmacology and behavioral addiction. She has been awarded several academic honors, including recognition for her groundbreaking research on gambling disorders, which was the first of its kind in Japan. Her work on cognitive enhancement therapies for schizophrenia has been published in high-impact journals, earning her a reputation as a leader in the field. While she has not yet received large-scale awards, her growing recognition within the academic community and her role as Chief Researcher at the National Institute of Mental Health reflect her increasing influence. Yamada’s contributions to psychiatric research have been acknowledged through invitations to present her findings at prestigious international conferences. She is also a member of several leading professional societies, including the Collegium Internationale Neuro-Psychopharmacologicum and the Japanese Society of Neuropsychopharmacology, further solidifying her status as a respected researcher.

Conclusion

Risa Yamada is a highly promising and accomplished researcher in the field of psychiatry, with a focus on neuropsychopharmacology, neurophysiology, and epidemiology. Her work has already made a significant impact, particularly in the understanding of cognitive dysfunction in schizophrenia and gambling disorders. With a robust educational background and extensive professional experience, Yamada is well-positioned to continue contributing to the advancement of psychiatric research. Her innovative approach to non-invasive brain stimulation, alongside her focus on biomarkers for psychiatric conditions, highlights her potential for further breakthroughs. While her research is primarily centered on schizophrenia and mood disorders, expanding her focus to other psychiatric conditions would enhance the breadth of her contributions. With continued growth in international collaboration and further emphasis on translational research, Yamada has the potential to make a lasting impact on both clinical practice and scientific understanding in the field of psychiatry.

Publications Top Notes

  • Clinical Significance of Psychiatric Comorbidities Among Outpatients With Gambling Disorder in Japan: A 12-Month Follow-Up Study
    Authors: Yamada, R., Stickley, A., Shigeta, M., Miyata, H.
    Year: 2025

  • Semantic memory disorganization linked to social functioning in patients with schizophrenia
    Authors: Wada, A., Sumiyoshi, C., Yoshimura, N., Hashimoto, R., Matsumoto, J., Stickley, A., Yamada, Y., Kikuchi, A., Kubota, R., Matsui, M., Nakachi, K., Fujimaki, C., Adachi, L., Yamada, R., Sumiyoshi, T.
    Year: 2025

  • Autistic trait severity in early schizophrenia: Role in subjective quality of life and social functioning
    Authors: Wada, A., Yamada, R., Yamada, Y., Sumiyoshi, C., Hashimoto, R., Matsumoto, J., Kikuchi, A., Kubota, R., Matsui, M., Nakachi, K., Fujimaki, C., Adachi, L., Stickley, A., Yoshimura, N., Sumiyoshi, T.
    Year: 2025

  • Problematic gambling and psychotic-like experiences: Findings from Japan
    Authors: Stickley, A., Shirama, A., Yamada, R., Sumiyoshi, T.
    Year: 2024

  • Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis
    Authors: Yamada, R., Wada, A., Stickley, A., Yokoi, Y., Sumiyoshi, T.
    Year: 2023

  • Effect of 5-HT1A Receptor Partial Agonists of the Azapirone Class as an Add-On Therapy on Psychopathology and Cognition in Schizophrenia: A Systematic Review and Meta-Analysis
    Authors: Yamada, R., Wada, A., Stickley, A., Yokoi, Y., Sumiyoshi, T.
    Year: 2023

  • Prevalence and Clinical Significance of Psychiatric Comorbidities With Gambling Disorder in 12 Clinical Settings in Japan
    Authors: Yamada, R., Miyashita, K., Hashimoto, T. M., et al.
    Year: 2023

  • Discrepancy between Clinician-rated and Self-reported Depression Severity is Associated with Adverse Childhood Experience, Autistic-like Traits, and Coping Styles in Mood Disorders
    Authors: Yamada, R., Fujii, T., Hattori, K., et al.
    Year: 2023

  • The relationship between severity of drug problems and perceived interdependence of drug use and sexual intercourse among adult males in drug addiction rehabilitation centers in Japan
    Authors: Yamada, R., Shimane, T., Kondo, A., Yonezawa, M., Matsumoto, T.
    Year: 2021

Saverio Cinti | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Prof. Dr. Saverio Cinti | Medicine and Dentistry | Best Researcher Award

Scientific Director of the Obesity Center of the Polytechnic University of Marche from Polytechnic University of Marche, Italy

Prof. Saverio Cinti is a distinguished researcher and academic in the field of obesity, adipose tissue physiology, and human anatomy. With over 35 years of experience in medical research and education, he has made groundbreaking contributions to the understanding of fat biology, metabolism, and obesity-related disorders. He has served as a Full Professor of Human Anatomy at Marche Polytechnic University and is currently the Scientific Director of the Obesity Center at the same institution. His prolific research output includes over 340 peer-reviewed publications, with an impressive H-index of 87 and 37,585 citations (Scopus), demonstrating his global influence in the scientific community. He has also authored books, contributed to over 20 book chapters, and holds multiple patents in the field of metabolic diseases. Prof. Cinti has been an invited speaker at prestigious institutions, including Harvard, Columbia, NIH, and the European Congress of Endocrinology. His contributions have been recognized with prestigious awards, such as the Blaise Pascal Medal and the Friedrich Wassermann Prize. As a pioneer in adipose tissue research, his work continues to shape the future of obesity treatment and metabolic health on an international scale.

Professional Profile

Education

Prof. Saverio Cinti’s academic journey began with a Doctor of Medicine (MD) degree from the University of Padua in 1974. He then pursued specialization in Internal Medicine at the University of Verona (1979) and Surgical Pathology at the University of Milan (1982). His advanced training provided him with a strong foundation in human anatomy, cellular biology, and pathology, which later became central to his research on obesity and adipose tissue. Over the years, he has continuously expanded his expertise, engaging in multidisciplinary medical research and international collaborations. His education has been complemented by extensive teaching experience, particularly in anatomy, histology, and obesity-related metabolic studies. His deep understanding of human anatomy and pathology has allowed him to bridge the gap between basic research and clinical applications. His affiliation with global institutions, including the University of Copenhagen and the University of Bonn, further highlights his role as a leading educator and researcher in the field. His academic background, combined with his dedication to continuous learning, has positioned him as a key figure in obesity and metabolic disorder research.

Professional Experience

Prof. Cinti has held several prominent academic and research positions over the past four decades. From 1984 to 2020, he was the Head of the Anatomy and Cell Biology Unit at the Department of Experimental and Clinical Medicine at Marche Polytechnic University. He served as a Full Professor of Human Anatomy from 1986 to 2020, where he played a crucial role in shaping medical education. His leadership extends beyond academia, as he has also been the Director of the Obesity Center at Marche Polytechnic University since 2011 and the Scientific Director of the Obesity Center since 2020. His international experience includes being an Affiliated Professor at the University of Copenhagen and a Distinguished Professor Emeritus at the University of Bonn. Additionally, he has served as the President of the Italian Society of Obesity (SIO) from 2008 to 2010. His long-standing involvement in clinical research and academic leadership has significantly contributed to advancements in obesity and adipose tissue research. His career is marked by extensive grant funding (~€2.5 million), numerous high-impact publications, and collaborative efforts in obesity and metabolic disease research.

Research Interest

Prof. Cinti’s research primarily focuses on adipose tissue biology, obesity mechanisms, and metabolic disorders. His work has provided crucial insights into the function, differentiation, and plasticity of adipocytes, particularly in relation to metabolic diseases such as diabetes and obesity. He has extensively studied the role of white, brown, and beige adipose tissue in energy metabolism and thermogenesis. His research also explores the cellular and molecular mechanisms of fat storage, lipid metabolism, and the impact of obesity on systemic health. A key aspect of his work involves understanding how adipose tissue dysfunction contributes to metabolic syndrome, cardiovascular diseases, and inflammation-related disorders. He has been actively involved in translational research, bridging laboratory discoveries with potential clinical applications for obesity treatment. His studies on leptin, irisin, and adipose-derived stem cells have contributed to the development of innovative therapies for metabolic diseases. Additionally, his research extends to regenerative medicine, focusing on adipose tissue engineering for tissue repair and renewal. His contributions continue to shape obesity research, paving the way for novel therapeutic approaches and a better understanding of adipose tissue biology.

Research Skills

Prof. Cinti possesses a diverse range of research skills, making him a leading authority in obesity and adipose tissue studies. He is highly skilled in electron microscopy, histological analysis, and molecular biology techniques, which he has used to investigate the structure and function of adipose tissues. His expertise in cellular and molecular biology has allowed him to make groundbreaking discoveries regarding adipocyte differentiation and metabolic regulation. He is proficient in animal models of obesity, metabolic syndrome, and diabetes, enabling him to conduct preclinical research on obesity treatments. His work also involves biochemical assays, gene expression analysis, and imaging techniques to study fat metabolism and energy homeostasis. Additionally, he has experience in clinical research methodologies, including patient-based studies on obesity, metabolic disorders, and regenerative medicine. His strong background in scientific writing and peer reviewing has led to contributions in top-tier journals such as Nature, Science, and Cell Metabolism. His ability to integrate basic science with clinical applications has made him a pioneer in translational obesity research.

Awards and Honors

Prof. Cinti has received numerous prestigious awards in recognition of his contributions to obesity research. In 2008, he was awarded the Blaise Pascal Medal by the European Academy of Science, a prestigious honor for his pioneering work in metabolic diseases. In 2013, he received the Friedrich Wassermann Prize from the European Association for the Study of Obesity (EASO), further highlighting his impact on obesity research. He has also been honored as a Distinguished Professor Emeritus at the University of Bonn and has been a plenary speaker at international conferences, including Harvard, Columbia University, and the European Congress of Endocrinology. He has served as a peer reviewer for leading journals such as Science, Nature, and Cell Metabolism, further cementing his reputation as a global expert in obesity and metabolic disorders. His extensive contributions have also been recognized through significant research funding (~€2.5 million over the last decade) and multiple patents related to obesity treatment and metabolic health. These awards and honors reflect his exceptional influence in the scientific community.

Conclusion

Prof. Saverio Cinti is an internationally renowned researcher whose groundbreaking work in obesity and adipose tissue biology has significantly advanced the field. With an illustrious career spanning over four decades, he has contributed extensively through research, education, and leadership roles. His vast publication record, high citation impact, and numerous awards showcase his global influence. His research has led to new insights into fat metabolism, obesity treatment, and regenerative medicine, positioning him at the forefront of translational obesity research. His commitment to scientific excellence, combined with his mentorship and leadership roles, has inspired countless researchers worldwide. Moving forward, expanding interdisciplinary collaborations, integrating emerging technologies, and increasing public outreach could further enhance his already significant impact. Prof. Cinti’s contributions make him a strong candidate for the Best Researcher Award, reflecting his exceptional dedication to scientific progress and medical innovation.

Publications Top Notes

  • Title: A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
    Authors: P. Boström, J. Wu, M.P. Jedrychowski, A. Korde, L. Ye, J.C. Lo, K.A. Rasbach, …
    Year: 2012
    Citations: 5879

  • Title: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1
    Authors: Z. Wu, P. Puigserver, U. Andersson, C. Zhang, G. Adelmant, V. Mootha, …
    Year: 1999
    Citations: 4936

  • Title: Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans
    Authors: S. Cinti, G. Mitchell, G. Barbatelli, I. Murano, E. Ceresi, E. Faloia, S. Wang, …
    Year: 2005
    Citations: 3248

  • Title: Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss
    Authors: R. Cancello, C. Henegar, N. Viguerie, S. Taleb, C. Poitou, C. Rouault, …
    Year: 2005
    Citations: 1498

  • Title: Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice
    Authors: P. Seale, H.M. Conroe, J. Estall, S. Kajimura, A. Frontini, J. Ishibashi, P. Cohen, …
    Year: 2011
    Citations: 1482

  • Title: Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice
    Authors: J. Lin, P.H. Wu, P.T. Tarr, K.S. Lindenberg, J. St-Pierre, C. Zhang, V.K. Mootha, …
    Year: 2004
    Citations: 1465

  • Title: The adipose organ
    Authors: S. Cinti
    Year: 2007
    Citations: 1161

  • Title: βAR signaling required for diet-induced thermogenesis and obesity resistance
    Authors: E.S. Bachman, H. Dhillon, C.Y. Zhang, S. Cinti, A.C. Bianco, B.K. Kobilka, …
    Year: 2002
    Citations: 1079

  • Title: Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch
    Authors: P. Cohen, J.D. Levy, Y. Zhang, A. Frontini, D.P. Kolodin, K.J. Svensson, J.C. Lo, …
    Year: 2014
    Citations: 967

  • Title: The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation
    Authors: G. Barbatelli, I. Murano, L. Madsen, Q. Hao, M. Jimenez, K. Kristiansen, …
    Year: 2010
    Citations: 948

  • Title: The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue
    Authors: M.C. Zingaretti, F. Crosta, A. Vitali, M. Guerrieri, A. Frontini, B. Cannon, …
    Year: 2009
    Citations: 915

  • Title: Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice
    Authors: I. Murano, G. Barbatelli, V. Parisani, C. Latini, G. Muzzonigro, M. Castellucci, …
    Year: 2008
    Citations: 879